Clinical relevance of semaphorin-3F in patients with prostate cancer. Wu, G. Clinical and Investigative Medicine 42 (3): E64-E69. 29 September 2019
![[feed]](/style/images/feed-icon-14x14.png){kind=icon}
![[up]](/style/images/multi_up.png)
Up a level
